4Kircheis G, Wettstein M, Dahl S, et al. Clinical efficacy of L - ornithine - L - aspartate in the management of hepatic encephalopathy [ J ]. Metab Brain Dis :2002,17 ( 4 ) : 453 - 462.
5Garcia - Tsao G, Lim JK. Management and treatment of patients with cirrhosis and portal hypertension:recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Pro- gram and the National Hepatitis C Program[ J]. Am J Gastroenterol 2009;104:1802 - 29.
6Aleom J. Review:rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy [ J ]. ACP J Club 2008 ; 149 : 11.
7Korula J. Review:lactulose or lactitol may improve hepatic enceph- alopathy but may be less effective than antibiotics[ J]. ACP J Club 2004;141:59.
8Bass NM, Mullcn KD, Sigal S, et al. Rifaximin is Effective in Maintaining Remission in Hepatic Eneephalopathy : results of a Large, Randomized, Placebo - Controlled Study [ J ]. J Hepatol 2009 ;50( S1 ) :539.
9Mihas AA. Persistent ascites and low serum sodium identify pa- tientswith cirrhosis and low MELD scores who are at high risk for early death [ J ]. Hepatology,2004,40 (4) : 80.
